InvestorsHub Logo

Investor2014

10/19/19 10:08 AM

#215337 RE: georgejjl #215334

Hopefully "Fact Checked By:

:
Özge Özkaya, PhD
Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.


Is equivalent to a full biochecked acknowledgement.

bennyboy1

10/19/19 11:39 AM

#215346 RE: georgejjl #215334

George - Thanks for that Anavex article in ALZHEIMER'S NEWS TODAY! This is an important and noteworthy happening in the PRESS!! I believe we are now on the DOORSTEP waiting to go THROUGH THE DOOR!!!! ANAVEX 2-73 can be the Human Health Drug for CNS Diseases!!!!! If anyone doesn't see what is happening they need to OPEN THEIR EYES WIDER and view GOD'S BLESSING!!!!!

falconer66a

10/19/19 12:23 PM

#215352 RE: georgejjl #215334

Very Accurate Presentation of Anavex Against Alzheimer’s

Yes, thank you for posting this link, to this Alzheimer’s group:
https://alzheimersnewstoday.com/anavex-2-73/

The author, Dr. Emily Malco, very accurately laid out the status of Anavex 2-73 trials in humans, and accurately told (in summary) the drug’s unique operation in neurons.

Until now, very little about Anavex has been posted or commented on by either Alzheimer’s associations or by Alzheimer’s researchers or therapists. They remain pretty much ignorant on the subject. But in this important venue the article reveals the significance and importance of the developing Anavex/Alzheimer’s story. For new, important audiences, it has opened the curtains on this expanding drama.

Soon, may the spotlight swing over to stage left, where positive clinical results will be exclaimed. Those will be elaborated on in every sort of publication. Everything changes, then.